Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?

To: Ron Sirch who wrote (392)	1/27/1999 6:14:00 PM
From: kukuiokala	Read Replies (1) \| Respond to of 471

Ron...you are well informed, I see, about CYBX. I can corroborate most of what you said. There are a couple of other large, very credible institutional holders as well. Clearly a good quarter. Clearly a unique technology. The Pharmaceutical giants, of course, would rather push their less effective, side affect producing drugs and can put some hurt on CYBX in the short run. In the long run, an effective, non-side affect producing, relatively non-intrusive solution will overcome the anti CYBX noise coming from other vendors. Thanks for sharing your insights. k